Symbols

KVUE

Kenvue·NYSE

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 1

High Gross Profit Margin

High Cash/net Profit Ratio

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About KVUE

Kenvue Inc.

A consumer health company worldwide

Industry

Personal care products

Established Date

02/23/2022

Listing Date

05/04/2023

Exchange

New York Stock Exchange

Full-time Employees

22,000

Fiscal Year Ends

12-31

Website

www.kenvue.com

Security Type

Common stock

Office address

1 Kenvue Way, Summit, New Jersey 07901

Business

Introduction

Kenvue Inc., was incorporated in Delaware on February 23, 2022. The company is the world's largest pure consumer health company. The company seeks to achieve sustainable profitable growth by delivering innovative products, solutions and experiences supported by science-based consumer health. With operations in more than 165 countries around the world and more than 135 years of tradition, they are a global leader at the intersection of healthcare and consumer products.

Company Financials

EPS

KVUE has released its 2025 Q4 earnings. EPS was reported at 0.27, versus the expected 0.33, missing expectations. The chart below visualizes how KVUE has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

KVUE has released its 2025 Q4 earnings report, with revenue of 3.78B, reflecting a YoY change of 3.22%, and net profit of 330.00M, showing a YoY change of 12.63%. The Sankey diagram below clearly presents KVUE's revenue sources and cost distribution.